In addition, FBLN5 acted as a target gene that can be regulated by miRNAs, such as miR-552/370/27a-3pp, thereby exerting the function of an anti-oncogene in NSCLC, breast cancer, and ovarian carcinoma [22, 35, 36]. Here, FBLN5 is linked to breast cancer.